| 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated … H Mitsuya, KJ Weinhold, PA Furman, MH St Clair, SN Lehrman, RC Gallo, ... Proceedings of the National Academy of Sciences 82 (20), 7096-7100, 1985 | 2728 | 1985 |
| Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. PA Furman, JA Fyfe, MH St Clair, K Weinhold, JL Rideout, GA Freeman, ... Proceedings of the National Academy of Sciences 83 (21), 8333-8337, 1986 | 1820 | 1986 |
| Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex R Yarchoan, KJ Weinhold, HK Lyerly, E Gelmann, RM Blum, GM Shearer, ... The Lancet 327 (8481), 575-580, 1986 | 1025 | 1986 |
| Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant GJ LaRosa, JP Davide, K Weinhold, JA Waterbury, AT Profy, JA Lewis, ... Science 249 (4971), 932-935, 1990 | 853 | 1990 |
| The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection N Goonetilleke, MKP Liu, JF Salazar-Gonzalez, G Ferrari, E Giorgi, ... Journal of experimental medicine 206 (6), 1253-1272, 2009 | 832 | 2009 |
| Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies … GD Tomaras, NL Yates, P Liu, L Qin, GG Fouda, LL Chavez, AC Decamp, ... Journal of virology 82 (24), 12449-12463, 2008 | 829 | 2008 |
| Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. TJ Palker, ME Clark, AJ Langlois, TJ Matthews, KJ Weinhold, RR Randall, ... Proceedings of the National Academy of Sciences 85 (6), 1932-1936, 1988 | 669 | 1988 |
| T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma K Woroniecka, P Chongsathidkiet, K Rhodin, H Kemeny, C Dechant, ... Clinical Cancer Research 24 (17), 4175-4186, 2018 | 506 | 2018 |
| HTLV-III/LAV-Neutralizing Antibodies to an E. coli-Produced Fragment of the Virus Envelope SD Putney, TJ Matthews, WG Robey, DL Lynn, M Robert-Guroff, ... Science 234 (4782), 1392-1395, 1986 | 472 | 1986 |
| A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection JD Hamilton, PM Hartigan, MS Simberkoff, PL Day, GR Diamond, ... New England Journal of Medicine 326 (7), 437-443, 1992 | 432 | 1992 |
| 3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase MH St Clair, CA Richards, T Spector, KJ Weinhold, WH Miller, AJ Langlois, ... Antimicrobial agents and chemotherapy 31 (12), 1972-1977, 1987 | 408 | 1987 |
| Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. TJ Matthews, KJ Weinhold, HK Lyerly, AJ Langlois, H Wigzell, ... Proceedings of the National Academy of Sciences 84 (15), 5424-5428, 1987 | 303 | 1987 |
| Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers G Ferrari, W Humphrey, MJ McElrath, JL Excler, AM Duliege, ... Proceedings of the National Academy of Sciences 94 (4), 1396-1401, 1997 | 301 | 1997 |
| Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. HK Lyerly, TJ Matthews, AJ Langlois, DP Bolognesi, KJ Weinhold Proceedings of the National Academy of Sciences 84 (13), 4601-4605, 1987 | 294 | 1987 |
| Standardization of cytokine flow cytometry assays HT Maecker, A Rinfret, P D'Souza, J Darden, E Roig, C Landry, P Hayes, ... BMC immunology 6, 1-18, 2005 | 279 | 2005 |
| High‐throughput quantitative analysis of HIV‐1 and SIV‐specific ADCC‐mediating antibody responses J Pollara, L Hart, F Brewer, J Pickeral, BZ Packard, JA Hoxie, A Komoriya, ... Cytometry Part A 79 (8), 603-612, 2011 | 264 | 2011 |
| HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. KJ Weinhold, HK Lyerly, SD Stanley, AA Austin, TJ Matthews, ... Journal of immunology (Baltimore, Md.: 1950) 142 (9), 3091-3097, 1989 | 260 | 1989 |
| Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection BF Haynes, LP Hale, KJ Weinhold, DD Patel, HX Liao, PB Bressler, ... The Journal of clinical investigation 103 (4), 453-460, 1999 | 240 | 1999 |
| Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both … ML Clements-Mann, K Weinhold, TJ Matthews, BS Graham, GJ Gorse, ... The Journal of infectious diseases 177 (5), 1230-1246, 1998 | 235 | 1998 |
| Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers RB Belshe, GJ Gorse, MJ Mulligan, TG Evans, MC Keefer, JL Excler, ... Aids 12 (18), 2407-2415, 1998 | 231 | 1998 |
